• <table id="gigg0"></table>
  • west china medical publishers
    Keyword
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Keyword "House-Brackmann" 2 results
    • Sanqi Tongshu Capsule for Acute Idiopathic Facial Paralysis: A Clinical Controlled Trial

      Objective To evaluate the effect of PNS on Idiopathic facial palsy. Methods A total of 86 cases of acute idiopathic facial paralysis were randomly divided into the treatment group (PNS group, 44 cases), and the control group (42 cases). The basis of the two groups included hormone therapy, B vitamins, anti-viral treatment, as well as acupuncture and physical therapy, both in the incidence of 7 days to give the treatment. House-Brackmann facial nerve function classification and evaluation were used to determine clinical efficacy; ENoG line was tested before and after treatment. Results Before H-B classification of facial nerve function, EnoG side of the latency and amplitude in the two groups were comparable. At 28 days after treatment, H-B scores for the treatment group and the control group were (2.33 ± 1.21) and (3.08 ± 1.35), respectively, and the two groups had significant differences (Plt;0.05); ENoG incubation period (2.46 ± 0.34) and amplitude (189 ± 67) of the treatment group were more than those of the control group; the incubation period (3.37 ± 0.49) and amplitude (131 ± 52) improved, and there were significant differences between the two groups (Plt;0.05). Comparison of efficacy of the two groups showed the total effective rate: 95.45% in the treatment group, 80.95% in the control group, and the efficacy of the treatment group was better than that of the control group (Plt;0.05). Conclusion Sanqi tongshu, B vitamins, anti-virus, such as the acupuncture and physical therapy for the treatment of acute idiopathic facial paralysis have significant effect.

      Release date:2016-08-25 02:51 Export PDF Favorites Scan
    • 阿昔洛韋治療特發性周圍性面癱

      目的 探討阿昔洛韋抗病毒治療對特發性周圍性面癱患者的治療作用。 方法 通過病例對照研究對2010年1月-2012年6月入院的特發性面癱患者78例,使用隨機表法隨機分為阿昔洛韋治療組和對照組,每組39例。治療2周,對兩組患者治療前、2周、4周及8周后使用House-Brackmann面神經分級標準進行評定面癱恢復情況。 結果 兩組患者面癱2 周緩解率分別為51.3%和48.7%;8周后面癱恢復率分別為84.6%和87.2%,差異均無統計學意義(P>0.05)。 結論 特發性面癱患者加用抗病毒治療療效未見明顯提高,不推薦常規使用抗病毒治療。

      Release date:2016-08-26 02:09 Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南